MENLO PARK, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and ...
Tuesday, 10.24.2017, Baltimore, MD, Insilico Medicine, a leader in the field of artificial intelligence, is pleased to announce its founder and CEO, Dr. Alex Zhavoronkov, will present at The World ...
WASHINGTON, Oct. 9, 2020 /PRNewswire/ -- Building on ground-breaking conferences in London (2017) and Washington (2019), Metabesity 2020 will be held online, with an all-access free pass option, on ...
VIENNA – There's a new term gaining attention in the health care sector. Defined as the "constellation of chronic noncommunicable diseases of aging," comprising cardiovascular disease, diabetes, ...
October 30, 2017, London, UK: Biogerontology Research Foundation (bg-rf.org.uk) Chief Science Officer, Dr. Alex Zhavoronkov and Biogerontology Research Foundation Advisor and Head of Business ...
Dr. William Haseltine, President of ACCESS Health International, will moderate All-Star Panel on at the Targeting Metabesity 2022 conference on October 11, 2022 ...
MENLO PARK, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and ...
Congresswoman Donna Shalala to join leading scientists, developers, regulators, and policy/business decision-makers who are seeking to accelerate translation of major scientific discoveries into ...
MENLO PARK, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results